- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/815 - Protease inhibitors from leeches, e.g. hirudin, eglin
Patent holdings for IPC class C07K 14/815
Total number of patents in this class: 33
10-year publication summary
|
2
|
4
|
2
|
3
|
0
|
1
|
0
|
1
|
0
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| PolyPeptide Laboratories Holding (ppl) AB | 38 |
4 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
2 |
| Lunan Pharmaceutical Group Corporation | 42 |
2 |
| Novetide, Ltd. | 10 |
2 |
| Teva Pharmaceuticals USA, Inc. | 971 |
2 |
| Ajinomoto Co., Inc. | 2314 |
1 |
| Baxter International Inc. | 2457 |
1 |
| Baxter Healthcare S.A. | 1847 |
1 |
| Antitope Limited | 6 |
1 |
| Cambridge Enterprise Limited | 1146 |
1 |
| CEM Corporation | 99 |
1 |
| Chengdu Shengnuo Tech Co., Ltd. | 3 |
1 |
| China Pharmaceutical University | 270 |
1 |
| Hybio Pharmaceutical Co., Ltd. | 120 |
1 |
| Kunming Institute of Zoology, Chinese Academy of Sciences | 37 |
1 |
| Kunming Longjin Pharmaceutical Co., Ltd. | 3 |
1 |
| Lonza Braine S.A. | 5 |
1 |
| Lonza Ltd. | 610 |
1 |
| NATCO Pharma Limited | 203 |
1 |
| National Research Council of Canada | 1567 |
1 |
| Other owners | 6 |